Literature DB >> 7236501

A comparative study of renal and hepatic function in Sprague-Dawley rats following systemic injection of purified carrageenans (kappa, lambda and iota).

A W Thomson, P H Whiting.   

Abstract

Renal and hepatic function was investigated in groups of 7 rats for 14 days after a single i.p. injection of 125 mg/kg purified kappa (kappa), lambda (lambda) or iota (iota) carrageenan. Kappa carrageenan was clearly nephrotoxic, as evidenced by a progressive, marked increase in serum creatinine and urea levels and in urinary N-acetyl-beta-D-glucosaminidase (NAG) activity. It also caused significant elevation in serum aspartate aminotransferase (AAT) activity from Day 2 to Day 7, and a progressive decrease in circulating albumin concentrations. Lambda carrageenan had no significant effect on serum creatinine or urea levels and caused only a transient increase in urinary NAG which was maximal on Day 2. Serum AAT levels were also significantly raised on Day 2. Iota carrageenan injection resulted in the deaths of 2/7 animals. Significant increases in serum creatinine levels were observed on Day 4: in 2 rats these increase were very pronounced as were those in urea levels, but no significant alterations in serum urea or urinary NAG levels were observed. No significant elevation in serum AAT was found, except for minor changes on Days 7 and 14. Whereas lambda carrageenan decreased serum albumin throughout the 14-day course of the experiment, albumin levels in lambda carrageenan-injected rats, whilst depressed during the first week, returned to normal by Day 14.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7236501      PMCID: PMC2041652     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  8 in total

1.  AUTOMATED AND MANUAL DIRECT METHODS FOR THE DETERMINATION OF BLOOD UREA.

Authors:  W H MARSH; B FINGERHUT; H MILLER
Journal:  Clin Chem       Date:  1965-06       Impact factor: 8.327

2.  Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs.

Authors:  C A WINTER; E A RISLEY; G W NUSS
Journal:  Proc Soc Exp Biol Med       Date:  1962-12

Review 3.  Shapely polysaccharides. The eighth Colworth medal lecture.

Authors:  D A Rees
Journal:  Biochem J       Date:  1972-01       Impact factor: 3.857

Review 4.  Biological properties of carrageenan.

Authors:  M Di Rosa
Journal:  J Pharm Pharmacol       Date:  1972-02       Impact factor: 3.765

Review 5.  The granulomatous inflammatory exudate.

Authors:  W G Spector
Journal:  Int Rev Exp Pathol       Date:  1969

6.  Histological and ultrastructural changes following carrageenan injection in the mouse.

Authors:  E F Fowler; J G Simpson; A W Thomson
Journal:  J Pathol       Date:  1980-09       Impact factor: 7.996

7.  A histopathological study of the effects of intravenously administered lambda carrageenan in the mouse, with particular reference to the macrophage system.

Authors:  P R Steele; J R Lowes
Journal:  Br J Exp Pathol       Date:  1979-08

8.  An examination of the cytotoxic effects of silica on macrophages.

Authors:  A C Allison; J S Harington; M Birbeck
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

  8 in total
  3 in total

Review 1.  Toxicological properties of carrageenan.

Authors:  M L Weiner
Journal:  Agents Actions       Date:  1991-01

2.  Analysis of daptomycin efficacy and breakpoint standards in a murine model of Enterococcus faecalis and Enterococcus faecium renal infection.

Authors:  Jeff Alder; Tongchaun Li; Donghui Yu; Larry Morton; Jared Silverman; Xi-Xian Zhang; Ian Critchley; Grace Thorne
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

3.  Haematological changes following systemic injection of purified carrageenans (kappa, lambda and iota).

Authors:  R J Davidson; J G Simpson; P H Whiting; J I Milton; A W Thomson
Journal:  Br J Exp Pathol       Date:  1981-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.